IFNG and neoplasm: These hybrid R-GEM/VNP-IFNγ cells leverage macrophage chemotaxis for tumor targeting, releasing bacteria that sustain antitumor effects while polarizing TAMs toward M1, maturing DCs, and expanding effector T cells across metastatic models [88].